Literature DB >> 1657918

Identification of a tissue-specific regulatory element within the human muscle glycogen phosphorylase gene.

J M Lockyer1, J B McCracken.   

Abstract

Northern blot analysis showed that human muscle glycogen phosphorylase is developmentally regulated in human adult and fetal skeletal muscle. Furthermore, muscle phosphorylase mRNA expression is temporally regulated in the C2C12 mouse muscle cell line. To define regulatory elements that control expression of the human muscle glycogen phosphorylase gene, the structure of the 5' end of the gene was determined, and 1,129 base pairs of the 5'-flanking region were subcloned and sequenced. Primer extension, RNase protection, and S1 nuclease protection experiments mapped the transcription start site to 76 base pairs upstream from the starting methionine. Sequential deletions of the 5'-flanking region were tested for the ability to activate chloramphenicol acetyltransferase (CAT) expression in fused or proliferating C2C12 cells. Inclusion of the 43 base pairs between -612 and -570 led to a 9-fold increase in CAT activity in fused myotubes. No increase was observed in proliferating myoblasts. This region contains a 10-base pair sequence, CTCCAAAAGG, at -592, which is also repeated at -252. Mutation of the sequence at -592 results in a 50% decrease in CAT activity compared with the amount of CAT activity observed with the normal or a control mutation. These results indicate that a regulatory element is found within -612 to -570 of the 5'-flanking DNA of the human muscle glycogen phosphorylase gene which activates transcription only in differentiated muscle cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657918

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Homozygosity by descent for a rare mutation in the myophosphorylase gene is associated with variable phenotypes in a Druze family with McArdle disease.

Authors:  S Iyengar; H Kalinsky; S Weiss; M Korostishevsky; M Sadeh; Y Zhao; K K Kidd; B Bonne-Tamir
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

2.  Three new mutations in patients with myophosphorylase deficiency (McArdle disease).

Authors:  S Tsujino; S Shanske; I Nonaka; Y Eto; J R Mendell; G M Fenichel; S DiMauro
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

3.  Adenovirus-mediated delivery into myocytes of muscle glycogen phosphorylase, the enzyme deficient in patients with glycogen-storage disease type V.

Authors:  S Baqué; C B Newgard; R D Gerard; J J Guinovart; A M Gómez-Foix
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

4.  Expression of the gene encoding glycogen phosphorylase is elevated in diabetic rat skeletal muscle and is regulated by insulin and cyclic AMP.

Authors:  C Reynet; C R Kahn; M R Loeken
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

5.  Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors.

Authors:  G B Athas; P Lobelle-Rich; L S Levy
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

6.  McArdle's disease. The unsolved mystery of the reappearing enzyme.

Authors:  A Martinuzzi; G Schievano; A Nascimbeni; M Fanin
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

7.  Expression of muscle-type phosphorylase in innervated and aneural cultured muscle of patients with myophosphorylase deficiency.

Authors:  A Martinuzzi; L Vergani; R Carrozzo; M Fanin; L Bartoloni; C Angelini; V Askanas; W K Engel
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.